139 related articles for article (PubMed ID: 10440771)
1. Restriction of the use of drugs with teratogenic properties: Swedish experiences with isotretinoin.
Källén B
Teratology; 1999 Aug; 60(2):53. PubMed ID: 10440771
[No Abstract] [Full Text] [Related]
2. [Isotretinoin embryopathy. Report of one case].
Troncoso Sch M; Rojas H C; Bravo C E
Rev Med Chil; 2008 Jun; 136(6):763-6. PubMed ID: 18769834
[TBL] [Abstract][Full Text] [Related]
3. The new teratogens: accutane and other vitamin-A analogs.
Thomson EJ; Cordero JF
MCN Am J Matern Child Nurs; 1989; 14(4):244-8. PubMed ID: 2501615
[No Abstract] [Full Text] [Related]
4. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.
Brinker A; Kornegay C; Nourjah P
Arch Dermatol; 2005 May; 141(5):563-9. PubMed ID: 15897377
[TBL] [Abstract][Full Text] [Related]
5. Potential subversion of pregnancy prevention program in the managed care setting.
Wilkin JK
Arch Dermatol; 1997 Feb; 133(2):243-4. PubMed ID: 9041846
[No Abstract] [Full Text] [Related]
6. Contraceptive efficacy.
Trussell J
Arch Dermatol; 1995 Sep; 131(9):1064-8. PubMed ID: 7661610
[TBL] [Abstract][Full Text] [Related]
7. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid.
Nau H
J Am Acad Dermatol; 2001 Nov; 45(5):S183-7. PubMed ID: 11606951
[TBL] [Abstract][Full Text] [Related]
8. Identification and management of oral isotretinoin use inconsistent with product labeling.
Wert S
Manag Care Interface; 2003 Mar; 16(3):41-3, 55. PubMed ID: 12715412
[TBL] [Abstract][Full Text] [Related]
9. [Isotretinoin (RoAccutane) embryopathy. A case report].
Pilorget H; Alessandri JL; Montbrun A; Ah-Hot M; Orvain E; Tilmont P
J Gynecol Obstet Biol Reprod (Paris); 1995; 24(5):511-5. PubMed ID: 7499738
[TBL] [Abstract][Full Text] [Related]
10. "Be smart, be safe, be sure". The revised Pregnancy Prevention Program for women on isotretinoin.
Perlman SE; Leach EE; Dominguez L; Ruszkowski AM; Rudy SJ
J Reprod Med; 2001 Feb; 46(2 Suppl):179-85. PubMed ID: 11255826
[TBL] [Abstract][Full Text] [Related]
11. Oral isotretinoin and pregnancy prevention programmes.
Thiboutot D; Gollnick H; Bettoli V; Dréno B; Kang S; Leyden JJ; Shalita A; Torres V;
Br J Dermatol; 2012 Feb; 166(2):466-7; author reply 467-8. PubMed ID: 21985025
[No Abstract] [Full Text] [Related]
12. A survey of pregnant women using isotretinoin.
Robertson J; Polifka JE; Avner M; Chambers C; Delevan G; Koren G; Lavigne SV; Martinez LP; Miller RK; Carey JC
Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):881-7. PubMed ID: 16228976
[TBL] [Abstract][Full Text] [Related]
13. [Isotretinoin (Roaccutan), a new teratogenic drug: which preventive strategies?].
Mastroiacovo P
Epidemiol Prev; 1988 Dec; 10(37):22-5. PubMed ID: 2978853
[No Abstract] [Full Text] [Related]
14. Oral isotretinoin: prescribers beware.
Shear NH
CMAJ; 1999 Jun; 160(12):1723-4. PubMed ID: 10410636
[No Abstract] [Full Text] [Related]
15. Human teratogens and evidence-based teratogen risk counseling: the Motherisk approach.
Nava-Ocampo AA; Koren G
Clin Obstet Gynecol; 2007 Mar; 50(1):123-31. PubMed ID: 17304029
[TBL] [Abstract][Full Text] [Related]
16. [Teratogenicity of isotretinoin].
Dos Santos AM; Vaillant C; Pedespan JM; Fontan D; Guillard JM
Arch Pediatr; 1998 Sep; 5(9):1046-7. PubMed ID: 9789644
[No Abstract] [Full Text] [Related]
17. Fetal exposure to oral isotretinoin: failure to comply with the Pregnancy Prevention Program.
Atanackovic G; Koren G
CMAJ; 1999 Jun; 160(12):1719-20. PubMed ID: 10410634
[No Abstract] [Full Text] [Related]
18. Can we ensure the safe use of known human teratogens? Introduction of generic isotretinoin in the US as an example.
Honein MA; Moore CA; Erickson JD
Drug Saf; 2004; 27(14):1069-80. PubMed ID: 15554743
[TBL] [Abstract][Full Text] [Related]
19. Oral retinoids. What should the prescriber known about their teratogenic hazards among women of child-bearing potential?
Mitchell AA
Drug Saf; 1992; 7(2):79-85. PubMed ID: 1605903
[No Abstract] [Full Text] [Related]
20. [Isotretinoin and pregnancy].
Revuz J
Ann Dermatol Venereol; 2000 Oct; 127(10):797-8. PubMed ID: 11060380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
